TRYP THERAPEUTICSCS INC
TRYP THERAPEUTICSCS INC
Share · CA89854F1062 · A2QKZP (XTSE)
Overview
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
1
0
0
0
No Price
n/a
Share Float & Liquidity
Free Float 159,73 %
Shares Float 154,01 M
Shares Outstanding 96,42 M
Asset Allocation
AssetPercentage %
Stock US62,20 %
Stock non-US37,72 %
Cash0,08 %
NotClassified0,00 %
Other0,00 %
Bond0,00 %
Largest Positions
SymbolISINNamePercentage %
HLTHilton Worldwide Holdings Inc 5,24 %
RY4CRyanair Holdings plc 5,07 %
MARMarriott International Inc 5,03 %
VICIVICI Properties Inc 4,54 %
DALDelta Air Lines Inc 4,50 %
RCLRoyal Caribbean Group 4,47 %
LUVSouthwest Airlines Co 4,39 %
HTHTHuazhu Group Limited 4,12 %
NCLHNorwegian Cruise Line Holdings Ltd 3,88 %
CCLCarnival Corporation & plc 3,86 %
Region Distribution
RegionPercentage %
North America62,64 %
Europe Developed13,47 %
United Kingdom6,98 %
Asia Emerging5,69 %
Asia Developed5,00 %
Japan4,93 %
Australasia1,30 %
Africa/Middle East0,00 %
Europe Emerging0,00 %
Latin America0,00 %
Sector Distribution
SectorPercentage %
Industrieunternehmen44,51 %
Verbrauchsgüter41,98 %
Immobilien13,51 %
Grundstoffe0,00 %
Finanzdienstleistungen0,00 %
Telekommunikation0,00 %
Energie0,00 %
Technologie0,00 %
Basiskonsumgüter0,00 %
Gesundheitswesen0,00 %
Company Profile for TRYP THERAPEUTICSCS INC Share
Tryp Therapeutics Inc., a pharmaceutical company, focuses on identifying and developing compounds for diseases with high unmet medical needs. The company's lead development program is (PFN), which is designed to treat neuropsychiatric disorders through the dosing of formulations of synthetic psilocybin. Its PFN program candidates include TRP-8802 and TRP-8803 for fibromyalgia, phantom limb pain, binge eating disorder, complex regional pain syndrome, and hypothalamic obesity. The company has an agreement with the Calvert Labs to design and execute exploratory studies related to psilocybin-for-neuropsychiatric disorders program; and a service agreement with Fluence to provide design and training for the psychotherapeutic portion of Tryp's clinical trial activities. The company was formerly known as Artos Pharma Corp. and changed its name to Tryp Therapeutics Inc. in June 2020. The company was incorporated in 2019 and is based in Kelowna, Canada.
Get up to date insights from finAgent about TRYP THERAPEUTICSCS INC
Fund Master Data
Issuer Toroso
Asset Class ETF
Name Tidal ETF Trust - SonicShares Airlines Hotels Cruise Lines ETF
Fund Currency USD
Category Consumer Cyclical
Fund Key Figures
Fund Size 3.891,34 EUR
Investment Strategy
The investment seeks to track the performance, before fees and expenses, of the Solactive Airlines, Hotels, Cruise Lines Index. The index?s initial investable universe consists of equity securities and depositary receipts of companies listed on exchanges in Australia, Brazil, Canada, Hong Kong, Israel, Japan, Mexico, New Zealand, Republic of South Korea, Singapore, Switzerland, United Kingdom, United States of America, or any member country of the European Union. At least 80% of the fund?s net assets, plus borrowings for investment purposes, will be invested in Airline Companies, Hotel Companies or Cruise Line Companies. It is non-diversified.

Company Data

Name TRYP THERAPEUTICSCS INC
Company Tryp Therapeutics Inc.
Website https://www.tryptherapeutics.com
Primary Exchange XTSE TSX
WKN A2QKZP
ISIN CA89854F1062
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Jason Carroll
Country Canada
Currency CAD
Employees -
Address 1665 Ellis Street, V1Y 2B3 Kelowna
IPO Date 2020-12-18

Ticker Symbols

Name Symbol
Over The Counter TRYPF
CSE LISTED TRYP.CN
More Shares
Investors who hold TRYP THERAPEUTICSCS INC also have the following shares in their portfolio:
Strategic Resources Inc.
Strategic Resources Inc. Share
US TREASURY 2043
US TREASURY 2043 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025